400 related articles for article (PubMed ID: 14631544)
1. Hyperviscosity in polycythemia vera and other red cell abnormalities.
Kwaan HC; Wang J
Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544
[TBL] [Abstract][Full Text] [Related]
2. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
3. Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera.
Pearson TC
Semin Thromb Hemost; 1997; 23(5):433-9. PubMed ID: 9387202
[TBL] [Abstract][Full Text] [Related]
4. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
5. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
6. Laboratory investigations and prediction of thrombotic risk in polycythemia vera.
Boneu B
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):183-5. PubMed ID: 8036139
[TBL] [Abstract][Full Text] [Related]
7. [Polycythemic hyperviscosity syndromes].
Tura S; Finelli C; Ricci P
Ric Clin Lab; 1983; 13 Suppl 3():105-14. PubMed ID: 6672989
[TBL] [Abstract][Full Text] [Related]
8. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
[TBL] [Abstract][Full Text] [Related]
10. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma viscosity in plasma cell dyscrasia and whole blood viscosity in polycythemia vera.
Shin DW; Gu JY; Kim JS; Jung JS; Shin DY; Koh Y; Kim I; Kim HK
Clin Hemorheol Microcirc; 2018; 70(1):59-67. PubMed ID: 29660912
[TBL] [Abstract][Full Text] [Related]
12. Abnormal adhesion of red blood cells in polycythemia vera: a prothrombotic effect?
El Nemer W; De Grandis M; Brusson M
Thromb Res; 2014 May; 133 Suppl 2():S107-11. PubMed ID: 24862129
[TBL] [Abstract][Full Text] [Related]
13. [Role of erythrocytes in thromboembolism pathology].
Wautier JL
Ann Med Interne (Paris); 1986; 137(6):477-9. PubMed ID: 3813282
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera: a review.
Golden C
Clin J Oncol Nurs; 2003; 7(5):553-6. PubMed ID: 14603552
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
Falanga A; Marchetti M; Barbui T; Smith CW
Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
[TBL] [Abstract][Full Text] [Related]
16. Rheological study on vascular occlusion and cellular hyperviscosity syndrome in polycythemia vera.
Fujioka S
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):688-95. PubMed ID: 2618545
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and management of bleeding in essential thrombocythemia and polycythemia vera.
Elliott MA; Tefferi A
Curr Hematol Rep; 2004 Sep; 3(5):344-51. PubMed ID: 15341701
[TBL] [Abstract][Full Text] [Related]
18. Role of plasma proteins in whole blood viscosity: a brief clinical review.
Kwaan HC
Clin Hemorheol Microcirc; 2010; 44(3):167-76. PubMed ID: 20364062
[TBL] [Abstract][Full Text] [Related]
19. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
Hernández-Boluda JC; Gómez M
Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
[TBL] [Abstract][Full Text] [Related]
20. Polycythemia vera.
Stuart BJ; Viera AJ
Am Fam Physician; 2004 May; 69(9):2139-44. PubMed ID: 15152961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
